skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:056572/0902   Pages: 6
Recorded: 06/17/2021
Attorney Dkt #:01138-0038-00US
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 2
1
Patent #:
NONE
Issue Dt:
06/11/2024
Application #:
17052333
Filing Dt:
11/02/2020
Publication #:
Pub Dt:
06/10/2021
Title:
Galnac Conjugated Modified Oligonucleotides as MIR-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-Effect
2
Patent #:
NONE
Issue Dt:
06/11/2024
Application #:
17052333
Filing Dt:
11/02/2020
Publication #:
Pub Dt:
06/10/2021
PCT #:
US2019031044
Title:
Galnac Conjugated Modified Oligonucleotides as MIR-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-Effect
Assignors
1
Exec Dt:
01/16/2019
2
Exec Dt:
01/08/2019
3
Exec Dt:
01/15/2019
Assignee
1
10614 SCIENCE CENTER DRIVE
SAN DIEGO, CALIFORNIA 92121
Correspondence name and address
MCNEILL BAUR PLLC
125 CAMBRIDGE PARK DRIVE
SUITE 301
CAMBRIDGE, MA 02140

Search Results as of: 05/23/2024 01:55 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT